NDC 73457-415

aspirin and omeprazole delayed-release tab

Aspirin And Omeprazole

aspirin and omeprazole delayed-release tab is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Innovida Therapeutique Corporation. The primary component is Aspirin; Omeprazole.

Product ID73457-415_b16f3bd8-7186-472e-8d02-a18d12fd1349
NDC73457-415
Product TypeHuman Prescription Drug
Proprietary Nameaspirin and omeprazole delayed-release tab
Generic NameAspirin And Omeprazole
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-11-13
Marketing CategoryNDA / NDA
Application NumberNDA205103
Labeler NameInnovida Therapeutique Corporation
Substance NameASPIRIN; OMEPRAZOLE
Active Ingredient Strength81 mg/1; mg/1
Pharm ClassesPlatelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 73457-415-80

30 TABLET, FILM COATED in 1 BOTTLE (73457-415-80)
Marketing Start Date2019-11-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 73457-415-80 [73457041580]

aspirin and omeprazole delayed-release tab TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205103
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN81 mg/1

Pharmacological Class

  • Platelet Aggregation Inhibitor [EPC]
  • Decreased Platelet Aggregation [PE]
  • Cyclooxygenase Inhibitors [MoA]
  • Decreased Prostaglandin Production [PE]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Proton Pump Inhibitor [EPC]
  • Proton Pump Inhibitors [MoA]
  • Cytochrome P450 2C19 Inhibitors [MoA]
  • Platelet Aggregation Inhibitor [EPC]
  • Decreased Platelet Aggregation [PE]
  • Cyclooxygenase Inhibitors [MoA]
  • Decreased Prostaglandin Production [PE]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Proton Pump Inhibitor [EPC]
  • Proton Pump Inhibitors [MoA]
  • Cytochrome P450 2C19 Inhibitors [MoA]

NDC Crossover Matching brand name "aspirin and omeprazole delayed-release tab" or generic name "Aspirin And Omeprazole"

NDCBrand NameGeneric Name
71800-014aspirin and omeprazole delayed-release tabaspirin and omeprazole
71800-018aspirin and omeprazole delayed-release tabaspirin and omeprazole
73457-415aspirin and omeprazole delayed-release tabaspirin and omeprazole
69597-348ASPIRIN/OMEPRAZOLEaspirin and omeprazole
64950-424Yospralaaspirin and omeprazole
64950-425Yospralaaspirin and omeprazole
70347-081YOSPRALAAspirin and Omeprazole
70347-325YOSPRALAAspirin and Omeprazole
71800-012Yospralaaspirin and omeprazole
71800-016Yospralaaspirin and omeprazole
73568-004Yospralaaspirin and omeprazole
73568-005Yospralaaspirin and omeprazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.